I think the overall interest in fsnr by the market is a great indicator for anyone to use as an evaluation. Petrozene is not new, it's been tested and tried before years ago and failed miserably. The fact that fsnr is attempting to incorporate it again shows the company's true desperation. Maybe a good evaluation for anyone to use would be the totality of fsnr's history, and its numerous, "highly touted" ventures, all of which fell miserably short of any market interests, and company claims.
News 
Market Data 
Discover 
